Biogen to pay $900 million to settle allegations it paid doctors kickbacks to prescribe multiple sclerosis drugs

A former Biogen employee, Michael Bawduniak, alleged Biogen paid kickbacks to doctors to encourage them to prescribe its multiple sclerosis drugs.